Summary:Lymphocytes play a major role in host defense against Aspergillus, but little is known about the contribution of dendritic cells (DC) to antifungal immunity in humans. We have observed that DC derived from normal volunteers phagocytose heat-killed A. fumigatus conidia. Following 24 h of exposure to the fungus, DC displayed an increase in the mean fluorescence intensity of HLA-DR, CD80, and CD86, and an increase in the percentage of CD54 + cells. These DC also displayed increased production of IL-12. DC derived from CD34 + progenitors or monocytes stimulated autologous lymphocytes to proliferate and produce high levels of interferon-␥, but not interleukin-10, in response to fungal antigen. DC generated from CD34 + progenitors collected prior to autologous or allogeneic stem cell transplantation also partially restored the in vitro antifungal proliferative response of lymphocytes obtained from patients 1 month after transplantation. These results suggest that DC are important to host-response to A. fumigatus, and that ex vivo-generated DC might be useful in restoring or enhancing the antifungal immunity after hematopoietic stem cell transplantation. Bone Marrow Transplantation (2001) 27, 647-652. Keywords: fungi; dendritic cell; immune reconstitution;
Candida; AspergillusThe ubiquitous mould Aspergillus rarely causes disease in healthy individuals but poses a serious threat to hematopoietic stem cell transplant recipients. [1][2][3] It is the most common etiology of non-Candida fungal infections occurring in these patients, and the case-fatality rate for invasive aspergillosis exceeds 80%. Although prolonged neutropenia is a well-established risk factor for Aspergillus infections, the majority of infections in the allogeneic setting become clinically evident well after engraftment, 2 suggesting that cell-mediated immunity plays an important role in protec- tion against this pathogen. Indeed, animal studies demonstrated that a Th1 response was associated with resistance to induction of experimental Aspergillus infection, 4 and methods stimulating a Th1 response were successful in inducing anti-Aspergillus immunity. 5 We 6 and others 7 have reported that a substantial proportion of blood and marrow transplant recipients have a deficiency in the number of circulating dendritic cells (DC) in the early post-transplant period. To overcome the potential effects of DC deficiency on immune reconstitution post transplant, DC-based vaccines have been used to induce T cell-mediated immunity to tumor early after transplantation. 8 However, despite the importance of DC in immunity, there is virtually no information regarding the role of human DC in resistance to aspergillosis. We have therefore evaluated the phagocytic capacity of human DC for A. fumigatus conidia, the cytokine response of human DC after exposure to A. fumigatus conidia, and the immunostimulatory competence of A. fumigatus conidia-pulsed DC for autologous lymphocytes from blood stem cell transplant recipients. The results of our studies suggest that DC ...